{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:59:46Z","timestamp":1772765986531,"version":"3.50.1"},"reference-count":138,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1517\/14740338.4.6.1111","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T10:38:45Z","timestamp":1130495925000},"page":"1111-1124","source":"Crossref","is-referenced-by-count":16,"title":["Atypical antipsychotic drugs, diabetes and ethnicity"],"prefix":"10.1517","volume":"4","author":[{"given":"Jambur","family":"Ananth","sequence":"first","affiliation":[{"name":"Metropolitan State Hospital, 11401 Bloomfield Avenue, Norwalk, CA 90650, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smitha","family":"Kolli","sequence":"additional","affiliation":[{"name":"Metropolitan State Hospital, 11401 Bloomfield Avenue, Norwalk, CA 90650, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarath","family":"Gunatilake","sequence":"additional","affiliation":[{"name":"Metropolitan State Hospital, 11401 Bloomfield Avenue, Norwalk, CA 90650, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Brown","sequence":"additional","affiliation":[{"name":"Metropolitan State Hospital, 11401 Bloomfield Avenue, Norwalk, CA 90650, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,10,28]]},"reference":[{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.9.1278"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(01)00161-1"},{"key":"e_1_2_1_5_1","first-page":"55","article-title":"Atypical antipsychotic agents and increased risk of diabetes: class action or differential action? Expert Opin","volume":"4","author":"ANANTH J","year":"2005","unstructured":"ANANTH J, KOLLI S: Atypical antipsychotic agents and increased risk of diabetes: class action or differential action? Expert Opin. Drug Sal: (2005) 4:55\u201368.","journal-title":"Drug Sal"},{"key":"e_1_2_1_6_1","first-page":"614","article-title":"Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women","volume":"145","author":"CAREY VJ","year":"1997","unstructured":"CAREY VJ, WALTERS EE, COLDITZ GA et al.: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am. J. Epidemiel (1997) 145:614\u2013619","journal-title":"The Nurses' Health Study. Am. J. Epidemiel"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.10.1758"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"HU FB SIGAL RJ RICH EDWARDS JW et al.: Walking compared with vigorous physical activity and risk of Type 2 diabetes in women: a prospective study. JAMA (1999) 282:1433\u20131439.","DOI":"10.1001\/jama.282.15.1433"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2003.01052.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-7-199504010-00001"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"DEFRONZO RA: Lilly lecture 1987. The triumvirate: beta- cell muscle liver. A collusion responsible for NIDDM. Diabetes (1988) 37:667\u2013687.","DOI":"10.2337\/diab.37.6.667"},{"key":"e_1_2_1_12_1","unstructured":"\u2022A good description of the pathophysiology of noninsulin-dependent diabetes."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(78)80007-9"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110398"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.42.11.1663"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","unstructured":"PIMENTA W MITRAKOU A JENSEN T YKI-JARVINEN H DALY G GERICH J: Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet. Med. (1996) 13\\(Supp6):s33\u2013s36.","DOI":"10.1002\/dme.1996.13.s6.33"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"KOPLAN JP LIVERMAN CT KRAAK VI (Eds): Preventing childhood obesity: Health in the balance. Washington DC: National Academies Press 2005.","DOI":"10.1037\/e407782005-001"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390404"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.407"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800541"},{"key":"e_1_2_1_21_1","unstructured":"WORLD HEALTH ORGANIZATION: Definition diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. WHO\/ NCD\/NCS\/99.2. Geneva: WHO (1999)."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"e_1_2_1_23_1","unstructured":"\u2022This reference discusses the applicability of body mass index for Asian populations."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0339"},{"key":"e_1_2_1_25_1","first-page":"1595","article-title":"lecture 1988","volume":"37","author":"REAVEN GM","year":"1998","unstructured":"REAVEN GM: BANTING: lecture 1988. Role of insulin resistance in human disease. Diabetes (1998) 37:1595\u20131607.","journal-title":"Role of insulin resistance in human disease. Diabetes"},{"key":"e_1_2_1_26_1","first-page":"374","volume":"334","author":"REAVEN GM","year":"1996","unstructured":"REAVEN GM, LITHELL H, LANDSBERG L.: Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl. I Med. (1996) 334:374\u2013381.","journal-title":"LANDSBERG L.: Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl. I Med."},{"key":"e_1_2_1_27_1","first-page":"13","article-title":"Syndrome X: 6 years later","volume":"236","author":"LIN REAVEN GM","year":"1994","unstructured":"LIN REAVEN GM: Syndrome X: 6 years later. I Intern. Med. Suppl. (1994) 236:13\u201322.","journal-title":"I Intern. Med. Suppl."},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.356"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.273.6.461"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1235"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910073411501"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg036"},{"key":"e_1_2_1_33_1","unstructured":"MENTAL HEALTH: CULTURE RACE AND ETHNICITY (A supplement to Mental Health): A report of the Surgeon General US Department of Health and Human Services US Public Health Service Rockville (2001)."},{"key":"e_1_2_1_34_1","unstructured":"\u2022\u2022The Surgeon General report discussesthe minorities and their health healthy delivery system and some solutions."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb025007"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb022863"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2519"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.3.670"},{"key":"e_1_2_1_39_1","first-page":"659","article-title":"Diabetes among Mexican Americans in Starr County, Texas","volume":"188","author":"HANIS CL","year":"1983","unstructured":"HANIS CL, FERRELL RE, BARTON SA et al.: Diabetes among Mexican Americans in Starr County, Texas. Americans in Star County, Texas. Am. J. Epidemiol (1983) 188:659\u2013672.","journal-title":"Americans in Star County, Texas. Am. J. Epidemiol"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","unstructured":"RAMASCHANDRAN A SNHELATA C DHARMARAJ D VISWANATHAM M: Prevalence of glucose intolerance in Asian Indians. Urban - rural difference and significance of upper body adiposity. Diabetes Care (1992) 15:32(5):408\u2013411.","DOI":"10.2337\/diacare.15.10.1348"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.10.1295"},{"key":"e_1_2_1_42_1","first-page":"670","article-title":"Differences bewteen Asian, Afro-Carribbean and white Caucasian Type 2 diabetic patients at diagnosis of diabetes","volume":"11","author":"UK PROSPECITVE DIABETIC STUDY XII","year":"1994","unstructured":"UK PROSPECITVE DIABETIC STUDY XII: Differences bewteen Asian, Afro-Carribbean and white Caucasian Type 2 diabetic patients at diagnosis of diabetes. UK Prosepctive Diabetes study group. Diabetic Med. (1994) 11:670\u2013677.","journal-title":"UK Prosepctive Diabetes study group. Diabetic Med."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.66"},{"key":"e_1_2_1_44_1","first-page":"pp 1","article-title":"Diagnosis, classification, and epidemiology of diabetes mellitus","author":"HARMEL AP","year":"1998","unstructured":"HARMEL AP, MATHUR R: Diagnosis, classification, and epidemiology of diabetes mellitus. In: Davidson's Diabetes Mellitus Diagnosis and Treatment Fifth Edition. Eds; Harmel AP and Mathur R. Saunders Philadelphia (1998) pp 1\u201322.","journal-title":"In: Davidson's Diabetes Mellitus Diagnosis and Treatment Fifth Edition. Eds; Harmel AP and Mathur R. Saunders Philadelphia"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.1.157"},{"key":"e_1_2_1_46_1","unstructured":"CENTER FOR DISEASE CONTROL: Prevalence of cigarette smoking among 14 racial and ethnic populations - United States 2001; Morbidity Mortality Weekly Report (2003) 52:953\u2013956."},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.6.935"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199907000-00012"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.7.1090"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00282581"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200309000-00007"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1501"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.7.1986"},{"key":"e_1_2_1_54_1","first-page":"324","article-title":"COSTA J","volume":"157","author":"ANANTH J","year":"2001","unstructured":"ANANTH J, GUNATILAKE S, AQUINO S, BACH V, COSTA J. Are African American patients at a higher risk for olanzapine-induced glucose intolerance? Psychopharmacology (Berl). (2001) 157:324\u20135.","journal-title":"Are African American patients at a higher risk for olanzapine-induced glucose intolerance? Psychopharmacology (Berl)."},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0517"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.3.725"},{"key":"e_1_2_1_57_1","first-page":"23","article-title":"genes and health-new wine in old bottles? Int","volume":"32","author":"COOPER RS","year":"2003","unstructured":"COOPER RS: Race, genes and health-new wine in old bottles? Int. J. Epidemiol (2003) 32:23\u201325.","journal-title":"J. Epidemiol"},{"key":"e_1_2_1_58_1","unstructured":"\u2022\u2022The difficulty in conducting ethnicresearch is eminently discussed."},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.46.1.63"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70078-1"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91500-9"},{"key":"e_1_2_1_62_1","first-page":"1357","article-title":"RAYMOND NT, MUGHAL S et al","volume":"21","author":"O'HARE JP","year":"2004","unstructured":"O'HARE JP, RAYMOND NT, MUGHAL S et al.: Evaluation of delivery of enhanced diabetes care to patients of South Asian Ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabet. Med. (2004) 21:1357\u20131365.","journal-title":"Evaluation of delivery of enhanced diabetes care to patients of South Asian Ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabet. Med."},{"key":"e_1_2_1_63_1","first-page":"313","article-title":"Black - White contrasts in insulin levels during pubertal development","volume":"41","author":"SVEC F NASTASI K, HILTON C, BAO W, SRINI VASAN SR, BERENSON GS","year":"1992","unstructured":"SVEC F NASTASI K, HILTON C, BAO W, SRINI VASAN SR, BERENSON GS: Black - White contrasts in insulin levels during pubertal development. The Bogalusa Heart study. Diabetes (1992) 41:313\u2013317","journal-title":"The Bogalusa Heart study. Diabetes"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/65.6.1703"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.8.1515"},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","unstructured":"UK PROSPECTIVE DIABETIC STUDY GROUP: UK prospective diabetic study 16. Overview of 6 years' therapy of Type 2 diabetes: a progressive disease. Diabetes (1995) 44:1249\u20131258.","DOI":"10.2337\/diab.44.11.1249"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400466"},{"key":"e_1_2_1_68_1","first-page":"190","article-title":"Prevalence of diabetes and impaired glucose tolerance in Nigerians Jamaicans and US Blacks","volume":"9","author":"ROTIMI CN","year":"1999","unstructured":"ROTIMI CN, COOPER RS, OKOSUN IS et al: Prevalence of diabetes and impaired glucose tolerance in Nigerians Jamaicans and US Blacks. Ethn. Dis. (1999) 9:190\u2013200.","journal-title":"Ethn. Dis."},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmr.5610050706"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.36.4.523"},{"key":"e_1_2_1_71_1","doi-asserted-by":"crossref","unstructured":"FUJIMOTO WY BERGSTROM RW BOYKO EJ et al.: Diabetes and diabetes risk factors in second and third generation Japanese-Americans in Seattle Washington. Diabetes Res. Clin. Pract. (1994) 24(Suppl.):543\u2013552.","DOI":"10.1016\/0168-8227(94)90226-7"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00282712"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.33.1.86"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.23.10.841"},{"key":"e_1_2_1_75_1","unstructured":"\u2022A valuable paper showing differential vulnerability for diabetes in Native American populations."},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607243150403"},{"key":"e_1_2_1_77_1","first-page":"101","article-title":"BENNETT P Hyperinsulinemia is a predictor of non-insulin-dependent diabetes mellitus","volume":"17","author":"ZIMMET P","year":"1991","unstructured":"ZIMMET P, DOWSE G, BENNETT P Hyperinsulinemia is a predictor of non-insulin-dependent diabetes mellitus. Diabet. Metab. (1991) 17:101\u2013108","journal-title":"Diabet. Metab."},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(93)90072-X"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(89)90002-4"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.60.5.390"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.14.6.917"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.39.3.390"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.32.5.408"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.67.5.341"},{"key":"e_1_2_1_85_1","unstructured":"\u2022Discusses coronary artery disease In Indian Pakistani and Bangladeshi populations."},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00421.x"},{"key":"e_1_2_1_87_1","first-page":"8","article-title":"Lower extremity amputations in NIDDM","volume":"11","author":"NEUFELD ND","year":"1988","unstructured":"NEUFELD ND, RAFFEL LJ, LAND ON C, CHEN YD, VADHEIM CM: Lower extremity amputations in NIDDM.12 year follow-up study in Pima Indians. Diabetic Care (1988) 11:8.","journal-title":"12 year follow-up study in Pima Indians. Diabetic Care"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2004.08.003"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114773"},{"key":"e_1_2_1_90_1","first-page":"54","article-title":"Consequences of obesity and body fat pattern: Lessons from migrant studies","volume":"201","author":"MCKEIGUE PM","year":"1996","unstructured":"MCKEIGUE PM: Metabolic Consequences of obesity and body fat pattern: Lessons from migrant studies. Ciba Foundation symposium (1996) 201:54\u201364.","journal-title":"Ciba Foundation symposium"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7042.1330"},{"key":"e_1_2_1_92_1","first-page":"343","article-title":"Coronary heart disease and its risk factors in first generation immigrant Asian Indians to the United States of America","volume":"48","author":"ENAS EA","year":"1996","unstructured":"ENAS EA, GARG A, DAVIDSON MA, NAIR VM, HUET BA, YUSUF S: Coronary heart disease and its risk factors in first generation immigrant Asian Indians to the United States of America. Indian Heart J. (1996) 48:343\u2013353.","journal-title":"Indian Heart J."},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.08.040"},{"key":"e_1_2_1_94_1","doi-asserted-by":"crossref","unstructured":"SODERBERG S ZIMMET P TUPMILEHTO J etal.: Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet. Med. (2005) 22:61\u201368.","DOI":"10.1111\/j.1464-5491.2005.01366.x"},{"key":"e_1_2_1_95_1","first-page":"421","article-title":"Hypertension and vasculardisease in India and migrant populations in the world","volume":"4","author":"SEEDAT YK","year":"1990","unstructured":"SEEDAT YK: Hypertension and vasculardisease in India and migrant populations in the world. J. Hum. Hypertens. (1990) 4:421\u2013424.","journal-title":"J. Hum. Hypertens."},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.5.952"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0414"},{"key":"e_1_2_1_98_1","first-page":"1371","article-title":"For the National Schizophrenia Guideline Development Group","volume":"321","author":"GEDDES J","year":"2000","unstructured":"GEDDES J, FREEMANTLE N, HARRISON P et al: For the National Schizophrenia Guideline Development Group. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BE Med. J. (2000) 321:1371\u20131376.","journal-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BE Med. J."},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.6.553"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00110-5"},{"key":"e_1_2_1_101_1","unstructured":"NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) Expert Panel in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Washington DC: National Heart Lung and Blood Institute National Institutes of Health US Department of Health and Human Services; September 2002:11\u201327. NIH publication 02\u20135215."},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1686"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.10.1837"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370104600308"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.4.337"},{"key":"e_1_2_1_106_1","unstructured":"\u2022Discusses the abnormalities of glucose regulation during antipsychotic treatment."},{"key":"e_1_2_1_107_1","unstructured":"HENDERSON DC CAGLIERO E GRAY C et al: Clozapine diabetes mellitus weight gain and lipid abnormalities: a five-year naturalistic study. Am. I Psychiatry (2004) 65\\(Suppl. 7):4\u201318."},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0509"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1010"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.862"},{"key":"e_1_2_1_111_1","first-page":"267","article-title":"American association of clinical endocrinologists","volume":"65","author":"AMERICAN DIABETIC ASSOCIATION, AMERICAN PSYCHIATRIC ASSOCIATION","year":"2004","unstructured":"AMERICAN DIABETIC ASSOCIATION, AMERICAN PSYCHIATRIC ASSOCIATION: American association of clinical endocrinologists. North American Association of the study of obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Am. J. Psychiatry (2004) 65:267\u2013272.","journal-title":"North American Association of the study of obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Am. J. Psychiatry"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.388-b"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.10.1571"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2003.tb11397.x"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1641-y"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.19"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01000-2"},{"key":"e_1_2_1_118_1","unstructured":"\u2022Provides practical guidelines for treatment with antipsychotic drugs and the monitoring needed to prevent diabetes."},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0619"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.11.841.33629"},{"key":"e_1_2_1_121_1","first-page":"11","article-title":"Phenomenology and risk factors for new onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases","volume":"22","author":"JIN H","year":"2002","unstructured":"JIN H, MAYER JM, JESTE DV: Phenomenology and risk factors for new onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann. Clin. Psychiatry (2002) 22:11\u201319.","journal-title":"Ann. Clin. Psychiatry"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1159\/000064807"},{"key":"e_1_2_1_123_1","unstructured":"\u2022This paper details the differential diabetogenic potential of different atypical antipsychotic drugs."},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.9.1471"},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815468"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.173.1.11"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.975"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(01)00234-7"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.6.553"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7273.1371"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1177\/014572170403000418"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2004.13.18.16140"},{"key":"e_1_2_1_133_1","unstructured":"GARVIN CC CHEADLE A CHRISMAN N CHEN R BRUNSON E: A community based approach to diabetes control in multiple cultural groups. Ethn. Dis. (2004) 14\\(Suppl. 1):S83\u2013S92."},{"issue":"26","key":"e_1_2_1_134_1","first-page":"35","article-title":"Diabetes in the Hispanic population","volume":"116","author":"IDROGO M","year":"2004","unstructured":"IDROGO M, MAZZE R: Diabetes in the Hispanic population. High risk warrants targeted screening and treatment. Post Grad. Med. (2004) 116:26-32,35\u201336.","journal-title":"High risk warrants targeted screening and treatment. Post Grad. Med."},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38279.588125.7C"},{"key":"e_1_2_1_136_1","unstructured":"INSTITUTE OF MEDICINE: Unequal treatment: confronting racial and ethnic disparities in health care. Washington (DC): National Academy Press (2002)."},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1709"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.16.1523"},{"key":"e_1_2_2_2_1","unstructured":"http:\/\/www. diabetes. org\/main\/info\/facts\/ facts_latinosjsp American Diabetes Association Diabetic facts and figures among latinos (2003)."}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.4.6.1111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:59:43Z","timestamp":1772762383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.4.6.1111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,28]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1517\/14740338.4.6.1111"],"URL":"https:\/\/doi.org\/10.1517\/14740338.4.6.1111","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,28]]}}}